Takeda Pharmaceutical Company Limited American Depositary Receipt (TAK) at a glance

Takeda Pharmaceutical Company Limited American Depositary Receipt (TAK) is a large-cap Healthcare company. It trades at $18.26, with a P/E of 42.7, a 4.3% profit margin and revenue growth of 3.9%. It pays a 4.2% dividend yield. Vestovix scores it 68/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Value (43/100). It is a relatively defensive holding with below-market volatility.

Price
$18.26
Market cap
$50.27B
P/E ratio
42.7
Dividend yield
4.22%
Beta
0.09
52-week range
$12.99 to $18.90
Vestovix Score68/ 100How this works
Value
43
Growth
75
Income
74
Safety
80
Momentum
79

Other Healthcare stocks

See all